ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation
- PMID: 31595650
- DOI: 10.1111/pcmr.12830
ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation
Abstract
Defining markers of different phenotypic states in melanoma is important for understanding disease progression, determining the response to therapy, and defining the molecular mechanisms underpinning phenotype-switching driven by the changing intratumor microenvironment. The ABCB5 transporter is implicated in drug-resistance and has been identified as a marker of melanoma-initiating cells. Indeed ongoing studies are using ABCB5 to define stem cell populations. However, we show here that the ABCB5 is a direct target for the microphthalmia-associated transcription factor MITF and its expression can be induced by β-catenin, a key activator and co-factor for MITF. Consequently, ABCB5 mRNA expression is primarily associated with melanoma cells exhibiting differentiation markers. The results suggest first that ABCB5 is unlikely to represent a marker of de-differentiated melanoma stem cells, and second that ABCB5 may contribute to the non-genetic drug-resistance associated with highly differentiated melanoma cells. To reconcile the apparently conflicting observations in the field, we propose a model in which ABCB5 may mark a slow-cycling differentiated population of melanoma cells.
Keywords: ABCB5; MITF; melanoma; stem cells; β-catenin.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., … Bressac-de Paillerets, B. (2011). A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature, 480, 94-98. https://doi.org/10.1038/nature10539
-
- Boiko, A. D., Razorenova, O. V., van de Rijn, M., Swetter, S. M., Johnson, D. L., Ly, D. P., … Weissman, I. L. (2010). Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature, 466, 133-137. https://doi.org/10.1038/nature09161
-
- Carreira, S., Goodall, J., Aksan, I., La Rocca, S. A., Galibert, M. D., Denat, L., … Goding, C. R. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature, 433, 764-769. https://doi.org/10.1038/nature03269
-
- Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K. S., … Goding, C. R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes & Development, 20, 3426-3439. https://doi.org/10.1101/gad.406406
-
- Cheli, Y., Bonnazi, V. F., Jacquel, A., Allegra, M., De Donatis, G. M., Bahadoran, P., … Ballotti, R. (2014). CD271 is an imperfect marker for melanoma initiating cells. Oncotarget, 5, 5272-5283. https://doi.org/10.18632/oncotarget.1967
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
